Yes. That's what I believe will be the case, Alba. It will all come down to how much of the expected $34m will be allocated for the placement with the remainder going to fpo holders on the basis of a 1 : 20 ratio.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
